Skip to main content

The Role of Naltrexone in the Treatment of Opioid Dependence

  • Chapter
Research Advances in Alcohol and Drug Problems

Abstract

For many years clinicians considered the treatment of opioid dependence with pessimism. But, over the last 15 years, even as the problem of addiction has grown, we have come to know more about the physiological and psychological bases of drug dependence; and we have developed a number of new pharmacologic and psychosocial modalities of treatment. These have met with varying degrees of success and have given physicians and patients alike varying degrees of hope or encouragement.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Arndt, I. O., in press, 1986, Cacciola, J. S., McLellan, A. T., O’Brien, C. P., A re-evaluation of naltrexone in recovering opiate addicts, in: Problems of Drug Dependence, 1985, NIDA Research Monograph Series, Rockville, Maryland.

    Google Scholar 

  • Brahen, L. S., Henderson, R. K., Copone, T., and Kordal, N., 1984, Naltrexone treatment in a jail work-release program, J. Clin. Psychiatry 45(2):49.

    Google Scholar 

  • Christian, M. S., 1984, Reproductive toxicity and teratology evaluations of naltrexone, J. Clin. Psychiatry 45:7.

    Google Scholar 

  • Gold, M. S., Redmond, D. E., and Kleber, H. D., 1978, Clonidine blocks acute opiate withdrawal symptoms, Lancet 2:599.

    Article  Google Scholar 

  • Grabowski, J., O’Brien, C. P., and Greenstein, R. A., 1979, Effects of contingent payment on compliance with a naltrexone regimen, Am. J. Drug Alcohol Abuse 6:355.

    Article  Google Scholar 

  • Greenstein, R. A., Evans, B. D., and McLellan, A. T., 1983, Predictors of favorable outcome following naltrexone treatment, Drug Alcohol Depend. 12:173.

    Article  Google Scholar 

  • Greenstein, R. A., Arndt, I. O., McLellan, T. A., O’Brien, C. P., and Evans, B. D., 1984, Naltrexone: A clinical perspective, J. Clin. Psychiatry 2:25.

    Google Scholar 

  • Hollister, L., 1978, Report of the National Research Council Committee on Clinical Evaluation of Narcotic Antagonists: Clinical evaluation of naltrexone treatment of dependent individuals, Arch. Gen. Psychiatry 35:335.

    Article  Google Scholar 

  • Judson, B. A., and Goldstein, A., 1984, Naltrexone treatment of heroin addiction: One year follow-up, Drug Alcohol Depend. 13:357.

    Article  Google Scholar 

  • Judson, B. A., Carney, T. M., and Goldstein, A., 1981, Naltrexone treatment of heroin addiction: Efficacy and safety in a double-blind dosage comparison, Drug Alcohol Depend. 7:325.

    Article  Google Scholar 

  • Kleber, H. D., and Kosten, T. R., 1984, Naltrexone induction: Psychologic and pharmacologic strategies, J. Clin. Psychiatry 2:29.

    Google Scholar 

  • Ling, W., and Wesson, D. R., 1984, Naltrexone treatment for addicted health-care professionals: A collaborative private practice experience, J. Clin. Psychiatry 2:46.

    Google Scholar 

  • Martin, W. R., and Jasinski, D. R., 1969, Physiological parameters of morphine in protracted abstinence, J. Psychiatr. Res. 7:9.

    Article  Google Scholar 

  • Martin, W. R., Jasinski, D. R., and Mansky, P. S., 1973, Naltrexone, an antagonist for the treatment of heroin dependence, Arch. Gen. Psychiatry 28:784.

    Article  Google Scholar 

  • Meyer, C. M., Straughn, B. A., Lo, M., Senary, L. W., and Whitney, C. C., 1984, Bioequivalence, dose-proportionality and pharmacokinetic of naltrexone after oral administration, J. Clin. Psychiatry 45(2):15.

    Google Scholar 

  • O’Brien, C. P., Greenstein, R., Mintz, J., and Woody, G. E., 1975, Clinical experience with naltrexone, Am. J. Drug Alcohol Abuse 2:365.

    Article  Google Scholar 

  • O’Brien, C. P., Childress, A. R., McLellan, A. T., and Ternes, J. W., 1984, Use of naltrexone to extinguish opioid-conditioned responses, J. Clin. Psychiatry 45(9):53.

    Google Scholar 

  • Rosenkrantz, H., 1984, Physiologic and morphologic changes and incidence of neoplasms in mice and rats fed naltrexone HCl for 24 months, J. Clin. Psychiatry 45(2):11.

    Google Scholar 

  • Sideroff, S. I., Charuvastra, V. C., and Jarvik, M. E., 1978, Craving in heroin addicts maintained on opiate antagonist naltrexone, Am. J. Drug Alcohol Abuse 5(4):415.

    Article  Google Scholar 

  • Tennant, F. S., Rawson, R. A., and Cohen, A. J., 1984, Clinical experience with naltrexone in suburban opioid addicts, J. Clin. Psychiatry 45(2):42.

    Google Scholar 

  • Washton, A. M., Pottash, A. C., and Gold, M. S., 1984, Naltrexone in addicted business executives and physicians, J. Clin. Psychiatry 45:9.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1986 Plenum Press, New York

About this chapter

Cite this chapter

O’Brien, C.P., Woody, G.E. (1986). The Role of Naltrexone in the Treatment of Opioid Dependence. In: Cappell, H.D., et al. Research Advances in Alcohol and Drug Problems. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-7743-0_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-7743-0_7

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4615-7745-4

  • Online ISBN: 978-1-4615-7743-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics